All In Biotech

Drug Trial Radar · NCT00247715

Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)

Comparison of an Antacid/H2-Receptor Antagonist/Proton Pump Inhibitor Versus a Proton Pump Inhibitor/H2-Receptor Antagonist/Antacid Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)

Last checked: Nov 20, 2026Latest source record: Aug 29, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 664 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

664

Actual

Start

Oct 2003

Primary completion

Not stated

Study completion Jan 2007

Sponsor

Lead sponsor
Radboud University Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
First posted
Nov 2, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to determine which treatment strategy, the step-up or the step-down treatment strategy, is the most cost-effective treatment for patients with new onset dyspepsia in primary care.

Conditions

  • Dyspepsia
  • Gastrointestinal Diseases

Interventions

  • algeldrate/magnesium oxideDrug

  • ranitidineDrug

  • pantoprazoleDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cost-efficacyTime frame: 6 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Radboud University Nijmegen Medical Center

    Nijmegen, Gelderland, Netherlands

  • Maastricht University

    Maastricht, Limburg, Netherlands

  • UMC Utrecht

    Utrecht, Utrecht, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.